1. Home
  2. FEDU vs GBIO Comparison

FEDU vs GBIO Comparison

Compare FEDU & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEDU
  • GBIO
  • Stock Information
  • Founded
  • FEDU 2007
  • GBIO 2016
  • Country
  • FEDU China
  • GBIO United States
  • Employees
  • FEDU N/A
  • GBIO N/A
  • Industry
  • FEDU
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEDU
  • GBIO Health Care
  • Exchange
  • FEDU NYSE
  • GBIO Nasdaq
  • Market Cap
  • FEDU 20.0M
  • GBIO 23.2M
  • IPO Year
  • FEDU 2017
  • GBIO 2020
  • Fundamental
  • Price
  • FEDU $6.96
  • GBIO $0.39
  • Analyst Decision
  • FEDU
  • GBIO Strong Buy
  • Analyst Count
  • FEDU 0
  • GBIO 4
  • Target Price
  • FEDU N/A
  • GBIO $7.33
  • AVG Volume (30 Days)
  • FEDU 16.5K
  • GBIO 559.5K
  • Earning Date
  • FEDU 12-20-2024
  • GBIO 05-12-2025
  • Dividend Yield
  • FEDU 32.71%
  • GBIO N/A
  • EPS Growth
  • FEDU N/A
  • GBIO N/A
  • EPS
  • FEDU 0.12
  • GBIO N/A
  • Revenue
  • FEDU $27,971,139.00
  • GBIO $19,892,000.00
  • Revenue This Year
  • FEDU N/A
  • GBIO N/A
  • Revenue Next Year
  • FEDU N/A
  • GBIO $10.90
  • P/E Ratio
  • FEDU $58.40
  • GBIO N/A
  • Revenue Growth
  • FEDU 141.14
  • GBIO 236.92
  • 52 Week Low
  • FEDU $3.69
  • GBIO $0.32
  • 52 Week High
  • FEDU $22.70
  • GBIO $4.34
  • Technical
  • Relative Strength Index (RSI)
  • FEDU 38.85
  • GBIO 43.58
  • Support Level
  • FEDU $5.50
  • GBIO $0.34
  • Resistance Level
  • FEDU $6.80
  • GBIO $0.40
  • Average True Range (ATR)
  • FEDU 1.20
  • GBIO 0.05
  • MACD
  • FEDU -0.13
  • GBIO 0.01
  • Stochastic Oscillator
  • FEDU 47.13
  • GBIO 61.29

About FEDU FOUR SEASONS EDUCATION (CAYMAN) INC SPON ADS EACH REP 10 ORD SHS(R/S)

Four Seasons Education (Cayman) Inc is engaged in the provision of after-school education services for kindergarten, elementary and middle school students. The Company derives its revenue from learning services, tourism services, and learning technology and content solutions. The company is a comprehensive educational enterprise that provides research practice services, educational informatization equipment, high-quality educational resources, and teacher training, as well as a digital publishing business, and continues to expand in educational research and educational informatization.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: